Indux is a drug that contains clomiphene citrate in its composition, which is indicated for the treatment of female infertility resulting from anovulation, characterized by inability to ovulate.Other causes of infertility or appropriate treatment should be excluded before starting Treatment with Indux.
This remedy can be purchased from conventional pharmacies for a price of about 20 to 30 reais, after prescription presentation, in the form of tablets with 50 mg of active substance.
- Indux is indicated to treat female infertility.
- Caused by the lack of ovulation.
- In addition.
- It can also be indicated to stimulate the production of eggs before performing artificial insemination or any other assisted reproduction technique.
Clomiphene citrate in Indux acts to induce ovulation in women who do not ovulate.Clomiphene competes with endogenous estrogens in estrogen receptors in the hypothalamus and leads to increased production of pituitary gonadotropins, responsible for the secretion of GnRH, LH and FSH.This increase causes stimulation, of the ovary, resulting in the maturation of the follicle and the development of the yellow body.Ovulation usually occurs 6 to 12 days after the Indux series.
Treatment with Indux should be done in 3 cycles, continuously or alternately, as directed by your doctor.
The recommended dose for the first treatment cycle is 1 tablet at 50 mg daily for 5 days. In women who do not have menstruation, treatment can be initiated at any time during the menstrual cycle. If menstrual induction is scheduled with progesterone or if spontaneous periods occur, the medicine should be given from the fifth day of the cycle.
If ovulation occurs with this dose, there is no benefit in increasing the dose over the next 2 cycles.If ovulation does not occur after the first treatment cycle, a second cycle should be performed at a dose of 100 mg, equivalent to 2 tablets., per day for 5 days, after 30 days of previous treatment.
Some of the most common side effects that may occur during treatment with Indux are increased size of the ovaries, hot flashes, visual symptoms, abdominal discomfort, nausea, vomiting, headache, abnormal uterine bleeding and pain when urinating.
This medicinal product should not be used in people with hypersensitivity to any of the components present in the formula, during pregnancy and lactation, in people with liver disease, with hormonodependent tumors, uterine hemorrhage of undetermined origin, ovarian cysts, with the exception of polycystic ovaries.